Clinical Trial Update: Effect Of DAAs For Treatment Of HCV On Normal Kidney [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on the effect of direct-acting antivirals (DAAs) for hepatitis C treatment on normal kidney function.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hepatitis C

Snippet

Sponsor: Assiut University | Conditions: Antiviral Drug Adverse Reaction | Phase 4 | Status: UNKNOWN